Noticias diarias
Noticias y actualizaciones de la industria farmacéutica
Noticias diarias
7 sept 2026•1 min de lectura
Systemic Lupus Erythematosus in Women 20‑40: Fatigue, Joint Pain, Rash
Persistent fatigue, joint pain and skin rash in women aged 20‑40 may indicate systemic lupus erythematosus, an autoimmune disease that mainly affects women of childbearing age.
Noticias diarias
7 sept 2026•1 min de lectura
‘1등약국 프로젝트’ 시즌 2 시작, 현장 약사 참여로 실무 경영 노하우 제공
‘1등약국 프로젝트’가 시즌 1을 마치고 시즌 2를 시작합니다. 현장 약사들이 직접 필진으로 참여해 인사·노무·매출·재고·고객·브랜딩 등 실질적인 약국 경영 주제를 다룹니다.
Noticias diarias
7 sept 2026•1 min de lectura
SK Biopharm invests in Opakalim (BHV‑7000) epilepsy candidate
SK Biopharm is investing heavily in the epilepsy drug candidate Opakalim (BHV‑7000) despite the lack of pivotal trial data, citing its potential, low CNS side effects and synergy with its US sales network.
Noticias diarias
7 sept 2026•1 min de lectura
Seoul Pharmacists Association Provides Hygiene Products and Supplements to Vulnerable Children and Youth
The Seoul Pharmacists Association delivered scholarships, sanitary pads, children's nutrition supplements, and health functional foods to group homes for at‑risk girls, easing hygiene costs and supporting health.
Noticias diarias
7 sept 2026•1 min de lectura
Gyeonggi Pharmacists Association and Student Group Sign Future Pharmacist Partnership Agreement
The Gyeonggi‑do Pharmacists Association and the Gyeonggi regional pharmacy student association signed a partnership agreement on Aug 24 to foster communication, mutual respect, and hands‑on public‑health experience for future pharmacists.
Noticias diarias
7 sept 2026•1 min de lectura
SK Biopharm Secures Global Rights to Opakalim, Expands Epilepsy Portfolio
SK Biopharm obtained worldwide rights to the epilepsy candidate Opakalim (BHV‑7000) and the Kv7 platform, marking its second epilepsy product after cenobamate.
Noticias diarias
7 sept 2026•1 min de lectura
Novartis Korea Holds Semblix STEP Symposium on CML Therapy
Novartis Korea held a two‑day symposium in Seoul to discuss the clinical value of Semblix (asciminib) and long‑term treatment strategies for chronic myeloid leukemia.
Noticias diarias
7 sept 2026•1 min de lectura
Solbit P&F Chairperson Son Won-rok’s Mother, Lee Young-ji, Passes Away at 90
Lee Young-ji, mother of Solbit P&F Chairperson Son Won-rok and CEO Woo Eun-ju, died at age 90. Funeral details are provided for the family and associates.
Noticias diarias
7 sept 2026•1 min de lectura
Daewoong Pharmaceutical joins Seoul’s “Blood‑Glucose Catch 9988” pre‑diabetes program
Daewoong Pharma will supply continuous glucose monitors and lifestyle‑management services to 1,000 Seoul citizens identified as pre‑diabetic (fasting glucose 100‑125 mg/dL).
Noticias diarias
6 sept 2026•1 min de lectura
Heat‑Related Exercise Risks: Rhabdomyolysis and Kidney Injury
High‑intensity or prolonged workouts in hot weather can cause rhabdomyolysis, releasing muscle substances that may lead to acute kidney injury.
Noticias diarias
6 sept 2026•1 min de lectura
Drug addiction counseling demand rises; 1342 hotline cases up 30% in July
The 1342 Yonggi Han Geolum Center recorded 5,150 counseling cases Jan‑July, with July volume 30% higher than January, highlighting growing demand.
Noticias diarias
6 sept 2026•1 min de lectura
Pharmacist advises against repeated strong back‑thumping for muscle relief during hiking
Pharmacist Kim Sun‑hye notes that while hitting the back on a tree can give a brief cooling sensation, repeated strong impacts do not enhance health benefits.